Dagrocorat (PF-00251802) 是一种具有口服活性，选择性和高亲和性部分糖皮质激素受体的激动剂。Dagrocorat 也是一种时间依赖性可逆抑制剂，对CYP3A (IC50=1.3 μM)和CYP2D6 (Ki=0.57 μM)有抑制作用。Dagrocorat 可用于类风湿性关节炎的研究。
| 生物活性 |
Dagrocorat (PF-00251802) is an orally active and selective high-affinity partial agonist of the glucocorticoid receptor. Dagrocorat is also a time-dependent reversible inhibitor of CYP3A (IC50=1.3 μM in human liver microsomes) and CYP2D6 (Ki=0.57 μM in human liver microsomes). Dagrocorat can be used for the research of rheumatoid arthritis. |
|---|---|
| 体外研究 |
Dagrocorat is metabolized by cytochrome P450 (CYP)3A to an N-oxide metabolite. Dagrocorat is a reversible inhibitor of several CYPs, such as CYP3A and CYP2D6. |
| 分子式 |
C29H29F3N2O2
|
| 分子量 |
494.55
|
| CAS号 |
1044535-52-5
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
纯度： 98%
关注我们
获得KKL MED 最新资讯
咨询热线：
400-881-9290
Data Sheet